Lupin launches Favipiravir at Rs 49 to treat mild to moderate COVID-19 disease Lupin launches Favipiravir at Rs 49 to treat mild to moderate COVID-19 disease Pratik Shastri / Wednesday, August 5, 2020 / Article rating: 3.8 The newly-launched drug, which was the need of the hour, would be available in the form of a strip of ten tablets, marketed under the brand name of Covihalt. It will be used to treat patients having a mild to moderate COVID-19 disease.
Zydus Cadila COVID-19 vaccine passes phase 1 human trials Zydus Cadila COVID-19 vaccine passes phase 1 human trials DSIJ Intelligence / Wednesday, August 5, 2020 / Article rating: 4.7 Global pharmaceutical major, Zydus Cadila announced on Wednesday that its plasmid DNA vaccine to prevent COVID-19, namely ZyCoV-D, was found to be well-tolerated and safe in phase 1 clinical trial.
Lupin gets US health regulator nod for Empagliflozin tablets Lupin gets US health regulator nod for Empagliflozin tablets DSIJ Intelligence / Wednesday, August 5, 2020 / Article rating: 4.3 Pharma major, Lupin Limited had announced on Tuesday that it has received regulatory approval from United States Food and Drug Administration (USFDA) for its Empagliflozin tablets, 10 mg and 25 mg to market a generic version of Jardiance tablets, 10 mg, and 25 mg, of Boehringer Ingelheim Pharmaceuticals.
Too many funds spoil the fun Too many funds spoil the fun DSIJ Intelligence / Wednesday, August 5, 2020 / Article rating: 4.0 Most people believe in the phrase, ‘the more the merrier’. However, that might not hold true with mutual funds. Read on to find out why.
Q1FY21 results: Cadila Healthcare profit jumps by 50 per cent YoY Q1FY21 results: Cadila Healthcare profit jumps by 50 per cent YoY DSIJ Intelligence / Wednesday, August 5, 2020 / Article rating: 3.8 The consolidated net sales reported in Q1FY21 came in at Rs 3,639.9 crore, which increased by 4.11 per cent YoY from Rs 3,496.3 crore in Q1FY20.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high DSIJ Intelligence / Wednesday, August 5, 2020 / Article rating: 4.1 The market opened in green on August 5, 2020.
Five stocks with buying interest Five stocks with buying interest DSIJ Intelligence / Wednesday, August 5, 2020 / Article rating: 3.5 The market opened in green on August 5, 2020, overall volumes in futures & options currently stand at 2,11,51,827 crore contracts with a turnover of Rs. 14,46,632.04 crore.
Five stocks with selling interest Five stocks with selling interest DSIJ Intelligence / Wednesday, August 5, 2020 / Article rating: 3.5 The market opened in green on August 5, 2020, overall volumes in futures & options currently stand at 2,11,51,827 crore contracts with a turnover of Rs. 14,46,632.04 crore.
Alembic Pharma gets USFDA approval for Vardenafil Hydrochloride tablets Alembic Pharma gets USFDA approval for Vardenafil Hydrochloride tablets Apurva Joshi / Wednesday, August 5, 2020 / Article rating: 4.0 Alembic Pharmaceuticals Limited has received final approval from United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Vardenafil Hydrochloride tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base).
Parag Milk Foods gain 3 per cent on further release of pledged shares Parag Milk Foods gain 3 per cent on further release of pledged shares Nidhi Jani / Wednesday, August 5, 2020 / Article rating: 4.0 The promoters have released 27 lakh equity shares, with reference to the earlier announcements. The promoters have informed the company that they have repaid Rs 58.09 crore and now the outstanding amount is Rs 5.91 crore.